This year Ramadan and Easter fall earlier than 2022, so we are looking at religious fasting and its impact on the management of diabetes during periods of abstinence and fasting. Two major religions, Islam and Christianity, have periods of fasting around this time of year (many other religions also have fast periods). Many people will have fasted before, so this may be just a reminder but for those of you who have not, we look at fasting practices and general issues around diabetes and fasting and hope we provide some helpful tips for staying safe and well during your fast.
Abbott has recently identified that certain FreeStyle Libre 2 sensors from lot KTP005061 may provide erroneously high glucose readings. For example, your sensor glucose reading may be high and out of your target range while your actual glucose levels may be below or within target range.
NHS patients in England with Type 1 diabetes are now eligible for a free continuous glucose monitor (CGM) after the health service secured a new ‘cost-effective’ deal.
Earlier this year, the NHS announced it would rollout CGM technology to everyone living with Type 1 diabetes as part of its ‘Long Term Plan’ to deliver world-class healthcare. Now a deal between the NHS and manufacturer DEXCOM means a CGM called the Dexcom ONE Real Time-Continuous Glucose Monitoring will soon be available on prescription to people with Type 1 diabetes.
The deepening crisis in Ukraine means that there is an increasingly desperate need to help people trying to live with diabetes. It is hard to believe that not only are the people of Ukraine having to fight for their country and freedom, but they also are in desperate need all their diabetes supplies. As the bombing continues, pharmacies close, hospitals run out of supplies and supply routes targeted.
A warning was issued in June 2022 by the Medicines and Healthcare products Regulatory Agency (MHRA) about metformin.
A National Patient Safety Alert was issued in June 2022 by the Medicines and Healthcare products Regulatory Agency (MHRA), following serious reports of harm associated with insulin leakage during use of the Accu-Chek Insight Insulin pump with NovoRapid PumpCart prefilled insulin cartridges. Patients should be moved on to alternative insulin pumps where possible
More than 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their condition and at the same time reduce the need for finger prick testing by up to 50%, following new advice from NICE. New guidance from NICE has recommended the use of real-time continuous glucose monitoring (rtCGM) for adults and children living with type 1 diabetes for the first time. It will give them a continuous stream of real-time information on a smartphone about their current blood glucose level.
This year’s conference was well attended and many attendees used the opportunity to network with others living with diabetes, sharing stories, online resources and forums, and arranging to meet up. For those who were unable to attend, here’s a brief summary of what took place.
Please click here to find out more about the presentations at this year’s conference
Tetris Pharma has announced that people living with diabetes in the UK now have access to Ogluo® (glucagon Pre-Filled Pen). This is the first ready-to-use, pre-mixed and pre-measured liquid glucagon injection to treat severe hypoglycaemia in adults, adolescents, and children aged two years and over.
An article in The New York Times on December 3rd made headlines that are especially important for people living with Type 1 diabetes. It announced that Brian Shelton from Ohio had been cured of Type 1 diabetes. Curing Type 1 requires a renewable source of beta cells that can be produced in the laboratory. Once placed into the body, they need to restore insulin production and automatically regulate blood-glucose levels.
AstraZeneca, in agreement with the European Medicines Agency and the [National Competent Authority], has made the following announcement:
Effective 25 October 2021 Forxiga (dapagliflozin) 5mg is no longer authorised for the treatment of patients with type 1 diabetes mellitus (T1DM) and should no longer be used in this population. This is based on Astra Zeneca’s decision to remove the T1DM indication for dapagliflozin 5mg.
If this affects you, then please discuss this with your consultant or healthcare team.
IDDT’s Chief Executive, Martin Hirst, has written an article for this week’s Diabetes Times, regarding the level of misleading information and terminology regarding diabetes, freely available on the internet.
This was a headline in November 2021 along with the statement that “Misdiagnosed Type 1 diabetes patients could be freed from the need to take insulin after a new test is rolled out.”
Scotland will become the first country to offer the C-peptide blood test to all patients who have had a Type 1 diagnosis for at least three years. The test became available from 1st November 2021 in Scotland.
Novo Nordisk has launched the PenCycle scheme to enable people to recycle their pre-filled FlexPen and FlexTouch devices by returning them to participating pharmacies or through pre-paid Royal Mail boxes which hold up to 12 used pens (with the needles removed).
This system, called PenCycle, started on 1st November 2021 and is being run in partnership with Alliance Healthcare, Lloyds Pharmacy, the National Pharmacy Association (NPA) and Royal Mail. It will be piloted in 13 clinical commissioning groups in Greater Manchester and Leicestershire and Rutland and in the Greater Glasgow and Clyde health board, ahead of a planned national rollout in 2022. The scheme is thought to be the first of its kind in the UK.
The DVLA has updated the guidance on glucose testing prior to driving. This now permits the use of interstitial glucose readings eg using Flash Glucose Scanning (FreeStyle Libre) and Continuous Glucose Monitoring (CGM) systems for Group 1 drivers only. However, finger-prick tests are still required (even for Group 1 drivers) under certain circumstances.
HM Government – Press Releases
25/08/2021
Patients should not stop any treatments without consulting their doctor or pharmacist.
A recall notice for one batch (10,452 units) of metformin oral solution has today been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) as a precautionary measure after it was found to contain a nitrosamine impurity above accepted levels.
By Martin Hirst
CEO, InDependent Diabetes Trust
Why should we talk about diabetes and tattoos?
Tattoos are a cultural phenomenon that exist in most parts of the world. They can be used to signify things like social status or family history as in Polynesian culture or as a form of art often seen, for example, in European culture. Tattoos tend to divide people into three groups, people who can’t bare them, people who love them and those who are “tattoo-curious”. Whichever group you belong to, tattoos by their very nature are here to stay. There are now over 12 million people in the UK who have been tattooed and not surprisingly some of them have diabetes as well and in this article we look at various aspects of getting tattooed if you have diabetes.
This final guideline has now been published and can be found by visiting the NICE website: https://www.nice.org.uk/guidance/NG17
This update is focused on the long-acting insulin recommendations only. Further updates will be published in due course.
The recommendations from this guideline have been included in the NICE Pathway on Type 1 diabetes in adults, which brings together everything we have said on Type 1 diabetes in adults: diagnosis and management (update) in an interactive flowchart. There is brief information about the guideline for people using services, carers and the public at ‘Information for the public’.
IDDT
IDDT Shop
Join Us
Please show your support by joining IDDT or renewing your membership now.
We rely on voluntary donations and appreciate any help you can give.
Find out the great benefits of becoming a member.
IDDT Helpline
IDDT has a CONFIDENTIAL Helpline,
find out more.
Donate
Want to donate?
You don’t have to be a member to donate, you can use the buttons below to donate from the Just Giving or Enthuse websites. Thank you.
IDDT Lottery
All the money that we raise through the IDDT Lottery goes directly to help people with diabetes and their families.
Find out more.
NICE Guidelines
NICE is an independent organisation responsible for providing national guidance on promoting good health.
Contact Info
InDependent Diabetes Trust
PO Box 294
Northampton
NN1 4XS
UK
01604 622837
01604 622838
enquiries@iddtinternational.org
An umbrella organisation
Looking for our Publications?
Looking for our Publications?
All IDDT publications are now accessible via the main Publications menu at the top of the page
Recycle to raise funds for IDDT
External Links
